Journal of Neuropathology & Experimental Neurology · 2001 · 1.9K citations · 49 references
Life SciencesNeurologyNeuroscienceDementiaNeurochemistryNeurodegenerationAlzheimer DiseaseNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersNeuropathology Of DementiaOxidative Damage To BiomoleculesAlzheimer Disease DementiaAlzheimer Disease ProgressionNeurodegenerative Disease BiomarkersNeurodegenerative Disease MechanismsOxidative Damage BiomarkersOxidative Stress - Induced NeurotoxicityOxidative Stress In NeurodegenerationProtein Oxidation In Neurodegeneration
The study aimed to determine whether oxidative damage is an early or late event in Alzheimer’s disease by examining its relationship with amyloid‑β plaques, neurofibrillary tangles, dementia duration, and ApoE genotype. Researchers assessed neuronal 8‑hydroxyguanosine and nitrotyrosine levels in relation to amyloid‑β plaques, neurofibrillary tangles, dementia duration, and ApoE genotype. Oxidative damage, measured by 8OHG and nitrotyrosine, peaks early in Alzheimer’s disease and declines as the disease progresses, with higher amyloid‑β deposition and neurofibrillary tangles—especially in ApoE ε4 carriers—associated with reduced oxidative markers, suggesting compensatory mechanisms that lower reactive‑oxygen damage over time.
Recently, we demonstrated a significant increase of an oxidized nucleoside derived from RNA, 8-hydroxyguanosine (8OHG), and an oxidized amino acid, nitrotyrosine in vulnerable neurons of patients with Alzheimer disease (AD). To determine whether oxidative damage is an early- or end-stage event in the process of neurodegeneration in AD, we investigated the relationship between neuronal 8OHG and nitrotyrosine and histological and clinical variables, i.e. amyloid-β (Aβ) plaques and neurofibrillary tangles (NFT), as well as duration of dementia and apolipoprotein E (ApoE) genotype. Our findings show that oxidative damage is quantitatively greatest early in the disease and reduces with disease progression. Surprisingly, we found that increases in Aβ deposition are associated with decreased oxidative damage. These relationships are more significant in ApoE ε4 carriers. Moreover, neurons with NFT show a 40%–56% decrease in relative 8OHG levels compared with neurons free of NFT. Our observations indicate that increased oxidative damage is an early event in AD that decreases with disease progression and lesion formation. These findings suggest that AD is associated with compensatory changes that reduce damage from reactive oxygen.
49
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Suzanne S. Mirra, Albert Heyman, Daniel W. McKeel et al. · Neurology · 1991 · 5.1K citations
Diagnosis of Alzheimer's Disease
Zaven S. Khachaturian · Archives of Neurology · 1985 · 2.5K citations
Medicine, Neurology, Psychiatry +13
Hydrogen peroxide mediates amyloid β protein toxicity
Christian Behl · Cell · 1994 · 2.1K citations